Trastuzumab Deruxtecan Benefit/Risk Profile in Advanced Cancer Supported by Pooled Analysis

Press/Media

Period	13 Apr 2021

Media coverage

Title	Trastuzumab Deruxtecan Benefit/Risk Profile in Advanced Cancer Supported by Pooled Analysis
Media name/outlet	OncLive
Country/Territory	United States
Date	13/04/21
URL	https://www.onclive.com/view/trastuzumab-deruxtecan-benefit-risk-profile-in-advanced-cancer-supported-by-pooled-analysis
Persons	Charles Powell